Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
172,779,139
-
Total 13F shares
-
61,353,442
-
Share change
-
+2,340,630
-
Total reported value
-
$2,685,754,151
-
Put/Call ratio
-
80%
-
Price per share
-
$43.89
-
Number of holders
-
160
-
Value change
-
+$108,882,886
-
Number of buys
-
94
-
Number of sells
-
66
Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q3 2024
As of 30 Sep 2024 Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) had 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 61,353,442 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, JANUS HENDERSON GROUP PLC, Capital Research Global Investors, Driehaus Capital Management LLC, FEDERATED HERMES, INC., BVF INC/IL, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., and Capital International Investors.
This table shows 160 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.